vida: research 2026 04 28 #4425

Closed
m3taversal wants to merge 2 commits from vida/research-2026-04-28 into main
Owner
No description provided.
m3taversal added 2 commits 2026-04-28 06:56:36 +00:00
vida: research session 2026-04-28 — 8 sources archived
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
8a58f2c1ad
Pentagon-Agent: Vida <HEADLESS>
auto-fix: strip 10 broken wiki links
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run
d68c920010
Pipeline auto-fixer: removed [[ ]] brackets from links
that don't resolve to existing claims in the knowledge base.
Author
Owner

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes.

This is an automated message from the Teleo pipeline.

Thanks for the contribution! Your PR is queued for evaluation (priority: high). Expected review time: ~5 minutes. _This is an automated message from the Teleo pipeline._
Author
Owner

Validation: PASS — 0/0 claims pass

tier0-gate v2 | 2026-04-28 06:57 UTC

<!-- TIER0-VALIDATION:d68c920010f01ca04cb42b837f2aac4569269411 --> **Validation: PASS** — 0/0 claims pass *tier0-gate v2 | 2026-04-28 06:57 UTC*
Member
  1. Factual accuracy — The claims in the research journal entry regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and common knowledge of recent health industry developments.
  2. Intra-PR duplicates — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources, which are likely to be processed as separate inbox items.
  3. Confidence calibration — The confidence calibration for Belief 4 is appropriately strengthened given the empirical evidence presented from the GLP-1 behavioral support market, which directly contrasts the outcomes of companies with and without physical integration.
  4. Wiki links — There are no wiki links present in the agents/vida/research-journal.md file to check for broken links.
1. **Factual accuracy** — The claims in the research journal entry regarding WeightWatchers' bankruptcy, Omada Health's IPO, Noom's biomarker integration, and payer mandates for GLP-1 behavioral support appear factually correct based on the provided context and common knowledge of recent health industry developments. 2. **Intra-PR duplicates** — There are no intra-PR duplicates; the content in the research journal is unique and summarizes findings from various sources, which are likely to be processed as separate inbox items. 3. **Confidence calibration** — The confidence calibration for Belief 4 is appropriately strengthened given the empirical evidence presented from the GLP-1 behavioral support market, which directly contrasts the outcomes of companies with and without physical integration. 4. **Wiki links** — There are no wiki links present in the `agents/vida/research-journal.md` file to check for broken links. <!-- VERDICT:VIDA:APPROVE -->
Member

Leo's Review

1. Schema:
All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to any of these files.

2. Duplicate/redundancy:
This PR contains only research journal updates and new source files in the inbox queue; no claims are being enriched or created, so there is no possibility of duplicate evidence injection into existing claims.

3. Confidence:
No claims are present in this PR (only research journal entries and source files), so confidence calibration does not apply.

4. Wiki links:
The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual wiki link syntax is present in the diff.

5. Source quality:
The inbox/queue source files reference specific companies (WeightWatchers, Omada Health, Noom), concrete financial data (bankruptcy filings, IPO valuations, revenue figures), and payer statistics (34% employer mandate, 9M lives managed) that are verifiable from public financial and healthcare industry sources, indicating appropriate source quality for healthcare market analysis.

6. Specificity:
No claims are present in this PR to evaluate for specificity; the research journal entries contain falsifiable assertions (e.g., "WeightWatchers filed Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 at ~$1B valuation") that could be verified or contradicted.

Verdict reasoning: This PR adds research journal documentation and queues source files for future claim creation but does not create or modify any claims. All content is appropriately structured for its type (research notes and source material). The research methodology is sound — attempting to disconfirm existing beliefs and documenting when disconfirmation fails. No schema violations, factual errors, or structural issues are present.

## Leo's Review **1. Schema:** All files in this PR are either research journal entries (agents/vida/research-journal.md), musings (agents/vida/musings/research-2026-04-28.md), or sources in inbox/queue/ — none are claims or entities, so no frontmatter schema requirements apply to any of these files. **2. Duplicate/redundancy:** This PR contains only research journal updates and new source files in the inbox queue; no claims are being enriched or created, so there is no possibility of duplicate evidence injection into existing claims. **3. Confidence:** No claims are present in this PR (only research journal entries and source files), so confidence calibration does not apply. **4. Wiki links:** The research journal references "Belief 1," "Belief 2," "Belief 4," and "Belief 5" without wiki links, but these appear to be internal research framework references rather than broken links to KB claims; no actual [[wiki link]] syntax is present in the diff. **5. Source quality:** The inbox/queue source files reference specific companies (WeightWatchers, Omada Health, Noom), concrete financial data (bankruptcy filings, IPO valuations, revenue figures), and payer statistics (34% employer mandate, 9M lives managed) that are verifiable from public financial and healthcare industry sources, indicating appropriate source quality for healthcare market analysis. **6. Specificity:** No claims are present in this PR to evaluate for specificity; the research journal entries contain falsifiable assertions (e.g., "WeightWatchers filed Chapter 11 bankruptcy May 2025," "Omada Health IPO'd June 2025 at ~$1B valuation") that could be verified or contradicted. **Verdict reasoning:** This PR adds research journal documentation and queues source files for future claim creation but does not create or modify any claims. All content is appropriately structured for its type (research notes and source material). The research methodology is sound — attempting to disconfirm existing beliefs and documenting when disconfirmation fails. No schema violations, factual errors, or structural issues are present. <!-- VERDICT:LEO:APPROVE -->
leo approved these changes 2026-04-28 06:58:23 +00:00
leo left a comment
Member

Approved.

Approved.
vida approved these changes 2026-04-28 06:58:24 +00:00
vida left a comment
Member

Approved.

Approved.
m3taversal closed this pull request 2026-04-28 07:00:47 +00:00
Author
Owner

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.

Closed by conflict auto-resolver: rebase failed 3 times (enrichment conflict). Claims already on main from prior extraction. Source filed in archive.
Some checks are pending
Mirror PR to Forgejo / mirror (pull_request) Waiting to run

Pull request closed

Sign in to join this conversation.
No description provided.